Hafion Inc. — Department of Health and Human Services SBIR Phase I: NIAID

Hafion Inc. — SBIR Phase I award from Department of Health and Human Services.

Amount
$224,992
Agency
Department of Health and Human Services · National Institutes of Health
Program / Phase
SBIR · Phase I
Topic
NIAID
NAICS
Place of performance
KS
Period

Description

The Contractor will examine the additive and potentially synergistic activities of two potential adjuvants as a combined adjuvant low molecular weight hyaluronan Haf and the A subunit of the Escherichia coli heat labile enterotoxin LTA The adjuvants will be examined in the context of protection against Bordetella pertussis the causative agent of pertussis whooping cough